financetom
Business
financetom
/
Business
/
Scottie Resources Completes Maiden Mineral Resource Estimate for Scottie Gold Mine DSO Project
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Scottie Resources Completes Maiden Mineral Resource Estimate for Scottie Gold Mine DSO Project
May 26, 2025 2:59 AM

02:07 PM EDT, 05/07/2025 (MT Newswires) -- Scottie Resources ( SCTSF ) on Wednesday said it completed its maiden inferred mineral resource estimate for its Scottie Gold Mine Project, which includes the mine, and the adjacent Blueberry Contact Zone in the Golden Triangle region in northwest British Columbia.

The inferred MRE shows 703,000 ounces of gold consisting of 528,000 ounces at 8.7 grams per tonne of underground resources and 174,000 ounces at 3.2 g/t in the shallow pit constrained resource. The company said the opportunity to further expand both the open pit and underground resources exists as the deposits are open in several directions.

"The release of the MRE is a significant milestone for the company as we advance our DSO (direct ship ore) project through studies towards production," said Chief Executive Brad Rourke. "A key aspect for us was the limited drilling needed to characterize this initial resource, which we believe signifies the considerable upside available through continued exploration."

During the 2025 exploration drilling campaign, Scottie said it will focus on converting the resources from inferred to indicated with infill drilling as well as expansionary drilling on high quality targets close to the deposits. It noted a particular benefit in targeting the undrilled pit-constrained envelope on the siltstone side of the deposit (a high-confidence target), as any additional ounces discovered will convert waste to resources and significantly improve the contained ounces.

Scottie added that it will continue to speed-up the project and expects to complete a preliminary economic assessment before the end of 2025, with the help of the "positive" MRE.

The company's shares were last seen down $0.04 to $0.87 on the TSX Venture Exchange.

Price: 0.87, Change: -0.04, Percent Change: -4.40

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
ArcBest Q2 Non-GAAP Net Income Rises, Revenue Falls
ArcBest Q2 Non-GAAP Net Income Rises, Revenue Falls
Aug 2, 2024
08:39 AM EDT, 08/02/2024 (MT Newswires) -- ArcBest ( ARCB ) reported Q2 non-GAAP net income Friday of $1.98 per diluted share, up from $1.54 a year earlier. Analysts polled by Capital IQ expected $2.06. Revenue for the quarter ended June 30 was $1.08 billion, down from $1.10 billion a year earlier. Analysts surveyed by Capital IQ expected $1.06 billion....
FDA Approves Adaptimmune Therapeutics' Engineered Cell Therapy As First For Solid Tumor And New Therapy For Rare Soft Tissue Cancer In Over A Decade
FDA Approves Adaptimmune Therapeutics' Engineered Cell Therapy As First For Solid Tumor And New Therapy For Rare Soft Tissue Cancer In Over A Decade
Aug 2, 2024
Thursday, the FDA approved Adaptimmune Therapeutics ( ADAP ) plc’s Tecelra (afamitresgene autoleucel) for unresectable or metastatic synovial sarcoma, a rare type of cancer that tends to occur near large joints, mainly the knees. The approval covers patients who have received prior chemotherapy, are HLA-A*02:01P, -A*02:02P, -A*02:03P, or -A*02:06P positive, and whose tumor expresses the MAGE-A4 antigen. This indication is approved under...
Integrated Electrical Services Fiscal Q3 Adjusted Earnings, Revenue Climb; Board Approves $200 Million Buyback
Integrated Electrical Services Fiscal Q3 Adjusted Earnings, Revenue Climb; Board Approves $200 Million Buyback
Aug 2, 2024
08:42 AM EDT, 08/02/2024 (MT Newswires) -- Integrated Electrical Services (IESC) reported fiscal Q3 adjusted earnings Friday of $2.67 per diluted share, up from $1.08 a year earlier. Revenue for the quarter ended June 30 was $768.4 million, up from $584.4 million a year earlier. Analysts' estimates were not readily available for comparison. The company also said its board has...
Twist Bioscience Fiscal Q3 Loss Widens, Revenue Rises; Lifts Revenue Outlook for Fiscal Q4, 2024
Twist Bioscience Fiscal Q3 Loss Widens, Revenue Rises; Lifts Revenue Outlook for Fiscal Q4, 2024
Aug 2, 2024
08:36 AM EDT, 08/02/2024 (MT Newswires) -- Twist Bioscience ( TWST ) reported a fiscal Q3 loss Friday of $1.47 per diluted share, widening from a loss of $1.01 a year earlier. Analysts polled by Capital IQ expected a per-share loss of $0.77. Revenue for the quarter ended June 30 was $81.5 million, up from $63.7 million a year earlier....
Copyright 2023-2026 - www.financetom.com All Rights Reserved